Opinion

Video

Key Barriers in Implementing Guideline-Directed Cholesterol Treatment

Author(s):

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP,Kate Cabral, PharmD, BCCP, FACC, FCCP

Clinical pharmacists discuss how to address key barriers that get in the way of implementing guideline-directed cholesterol treatment.

Related Videos
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
Related Content
LDL (Bad) lipoprotein (cholesterol) in the blood flow – Closeup view 3d illustration
April 18th 2025

Lepodisiran Reduces Lipoprotein(a) By Nearly 94% in Adults With Elevated Levels of Lp(a)

Luke Halpern, Assistant Editor
Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange
April 14th 2025

Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange

Alexandra Gerlach, Associate Editor
Low HDL-C, Triglyceride Levels in Late Life Independently Associated With Alzheimer Disease and Related Dementias
April 3rd 2025

Low HDL-C, Triglyceride Levels in Late Life Independently Associated With Alzheimer Disease and Related Dementias

Luke Halpern, Assistant Editor
Hyperlipidemia or arteriosclerosis. Blocked artery concept and human blood vessel as a disease with cholesterol fat buildup clogging. Clogged arteries, Cholesterol plaque in the artery.
March 28th 2025

Very Low LDL-C Achieved With Evolocumab Not Associated With Long-Term Cognitive Impairment

Luke Halpern, Assistant Editor
High Low-Density Lipoprotein Cholesterol Associated With Improved Survival in Acutely Decompensated Heart Failure
March 27th 2025

High Low-Density Lipoprotein Cholesterol Associated With Improved Survival in Acutely Decompensated Heart Failure

Luke Halpern, Assistant Editor
Cholesterol plaque in artery
March 21st 2025

Elevated Non-HDL Cholesterol a Stronger Indicator of Major Cardiovascular Events Compared With LDL-C

Luke Halpern, Assistant Editor